3Q16 Public-Private Partnership Roundup

Formation of new PPPs cooled off considerably this summer after a blistering pace in 2Q16, with the fewest preclinical research-oriented partnerships since 3Q14. Only 37 partnerships were recorded by BioCentury in 3Q16, a nearly 50% drop from 71 in the last quarter (see “New Public-Private Partnerships (PPPs)”).

Four of the deals were for new consortia, defined by BioCentury Innovations as PPPs having four or more partners, continuing the trend- often called “consortia fatigue” - away from the multilateral partnerships. This year, 14 consortia have been formed, slightly down from 16 during the same period in 2015. ...